The United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015. Australia hasn’t followed suit, though flib
Given time, the final four contestants in the Next Top Trainer contest, sponsored by EAS, are smart enough and knowledgeable enough to overcome pretty much any obstacle.